Biochemia Medica最新文献_第2页

YKL-40 as a biomarker in various inflammatory diseases: A review YKL-40 作为各种炎症性疾病的生物标记物：综述

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010502

Nina Blazevic, Nina Blazevic, Dunja Rogic, Stipe Pelajic, Marijana Miler, Goran Glavcic, Valentina Ratkajec, Nikolina Vrkljan, Dejan Bakula, Davor Hrabar, Tajana Pavic

引用次数: 0

Challenges of providing biochemistry results in a patient with Evans syndrome 为埃文斯综合征患者提供生化结果的挑战

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.011001

Natividad Rico Ríos, Natividad Rico Ríos, Alison Bransfield, Caroline M Joyce, Mary R Cahill, Michelle O’Shaughnessy, Seán J. Costelloe

引用次数: 0

Determination of cystatin C reference interval for children in Croatia 确定克罗地亚儿童胱抑素 C 参考区间

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010702

Vlasta Cigula Kurajica, Vlasta Cigula Kurajica, Željka Vogrinc, Ana Turčić, Slobodan Galić

引用次数: 0

Point of care testing in Croatia: a survey of the Working group for point of care testing of the Croatian society of medical biochemistry and laboratory medicine 克罗地亚的护理点检测：克罗地亚医学生物化学和实验室医学学会护理点检测工作组的调查

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010703

Ivana Baršić Lapić, Ivana Baršić Lapić, Lara Milevoj Kopčinović, Nedjeljka Ruljančić, Nedjeljka Ruljančić, Marija Grdić Rajković, Maja Kuštro

引用次数: 0

Detecting the interferences in adrenocorticotropic hormone measurement - three cases reinforcing the efficiency of the complementary clinical and laboratory audit 检测促肾上腺皮质激素测量中的干扰--三个案例强化了临床和实验室互补审计的效率

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010802

Tugba Barlas, Tugba Barlas, Mehmet Muhittin Yalcin, Zakir Osmanov, Ozlem Gulbahar, Alev Eroglu Altinova, Mujde Akturk, Mehmet Ayhan Karakoc, Ilhan Yetkin, Fusun Balos Toruner

引用次数: 0

Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review 作为环丙沙星不良反应的抗利尿激素分泌失调综合征：病例报告和文献综述

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010803

Luka Švitek, Luka Švitek, Barbara Grubišić, Barbara Grubišić, Ema Schonberger, Ema Schonberger, Mihaela Zlosa, Mihaela Zlosa, Dario Sabadi, Dario Sabadi, Dario Sabadi, Dubravka Lišnjić, Dubravka Lišnjić, Silvija Canecki-Varžić, Silvija Canecki-Varžić, Ines Bilić-Ćurčić, Ines Bilić-Ćurčić, Sanja Mandić, Sanja Mandić, Sanja Mandić

引用次数: 0

Paraoxonase and arylesterase activity of paraoxonase 1 and oxidative stress parameters in cervical intraepithelial neoplasia 宫颈上皮内瘤变中副氧杂蒽酮酶和副氧杂蒽酮酶 1 的芳基酯酶活性以及氧化应激参数

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010701

Dražan Butorac, Ivana Ćelap, Ivana Ćelap, Sanja Kačkov Maslać, Tomislav Miletić, Andrea Hulina Tomašković, Petra Turčić, Dubravka Rašić, Ivana Stojanović, Marija Grdić Rajković, Marija Grdić Rajković

引用次数: 0

Potential biomarkers and therapeutic targets for obsessive compulsive disorder: Evidences from clinical studies 强迫症的潜在生物标志物和治疗目标：临床研究证据

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-12-19 DOI: 10.11613/bm.2024.010503

Aarushi Sultania, Shashank Venkatesan, Dhruv Rishb Batra, Keerthna Rajesh, Rahul Vashishth, Sudesh Ravi, Faraz Ahmad, Faraz Ahmad

引用次数: 0

Diagnostic challenges of diabetic kidney disease. 糖尿病肾病的诊断挑战。

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-10-15 Epub Date: 2023-08-05 DOI: 10.11613/BM.2023.030501

Marijana Vučić Lovrenčić, Sandra Božičević, Lea Smirčić Duvnjak

{"title":"Diagnostic challenges of diabetic kidney disease.","authors":"Marijana Vučić Lovrenčić, Sandra Božičević, Lea Smirčić Duvnjak","doi":"10.11613/BM.2023.030501","DOIUrl":"10.11613/BM.2023.030501","url":null,"abstract":"Diabetic kidney disease (DKD) is one of the most common microvascular complications of both type 1 and type 2 diabetes and the most common cause of the end-stage renal disease (ESRD). It has been evidenced that targeted interventions at an early stage of DKD can efficiently prevent or delay the progression of kidney failure and improve patient outcomes. Therefore, regular screening for DKD has become one of the fundamental principles of diabetes care. Long-established biomarkers such as serum-creatinine-based estimates of glomerular filtration rate and albuminuria are currently the cornerstone of diagnosis and risk stratification in routine clinical practice. However, their immanent biological limitations and analytical variations may influence the clinical interpretation of the results. Recently proposed new predictive equations without the variable of race, together with the evidence on better accuracy of combined serum creatinine and cystatin C equations, and both race- and sex-free cystatin C-based equation, have enabled an improvement in the detection of DKD, but also require the harmonization of the recommended laboratory tests, wider availability of cystatin C testing and specific approach in various populations. Considering the complex pathophysiology of DKD, particularly in type 2 diabetes, a panel of biomarkers is needed to classify patients in terms of the rate of disease progression and/or response to specific interventions. With a personalized approach to diagnosis and treatment, in the future, it will be possible to respond to DKD better and enable improved outcomes for numerous patients worldwide.","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9949076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series. 疑似血管炎患者抗核抗体对抗中性粒细胞胞浆抗体测定的干扰：一系列病例。

IF 3.3 3区医学

Biochemia Medica Pub Date : 2023-10-15 Epub Date: 2023-08-05 DOI: 10.11613/BM.2023.031001

Mala Mahto, Neha Rai, Pulak Ranjan Das, Saurabh Karmakar, Divendu Bhushan

{"title":"Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series.","authors":"Mala Mahto, Neha Rai, Pulak Ranjan Das, Saurabh Karmakar, Divendu Bhushan","doi":"10.11613/BM.2023.031001","DOIUrl":"10.11613/BM.2023.031001","url":null,"abstract":"Anti-neutrophil cytoplasmic antibodies (ANCA) are mainly associated with medium and small vessel vasculitis. Two main methodologies currently available for detection of these antibodies are indirect immunofluorescence (IIF) and monospecific proteinase 3 (PR3) and myeloperoxidase (MPO) based immunoassays. However, well-defined guidelines regarding mode of testing for ANCA in laboratories still don't exist, leading to problems in diagnosis and further patient management. Anti-neutrophil cytoplasmic antibodies testing by IIF and enzyme linked immunosorbent assay (ELISA) often pose a significant challenge in diseases other than vasculitis and in overlapping autoimmune conditions. Anti-neutrophil cytoplasmic antibodies reporting by IIF can be challenging in certain circumstances. This case series aims to discuss four cases with probable interference of anti-nuclear antibodies (ANA) during ANCA testing by IIF resulting in ANCA false positivity. All four cases on subsequent reflex testing by line immunoassay (LIA) for PR3, MPO and glomerular basement membrane (GBM) antigens proved otherwise. While analysing for the presence of ANCA by IIF, the possible interference of ANA leading to a false positive ANCA result should be kept in mind and alternative methods of testing like ELISA, extended granulocyte based IIF assays with MPO and PR3 coated beads, etc., should also be advised. Probability of atypical ANCA in diseases other than vasculitis should also be considered in case of ambiguous results.","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9954831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0